Susquehanna International Group, LLP Athira Pharma, Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	BUY	$1.92 - $2.71 $92,160 - $130,080	48,000 Added 130.08%	84,900 $224,000
Q1 2024 May 07, 2024	BUY	$2.24 - $4.15 $82,656 - $153,135	36,900 New	36,900 $101,000
Q1 2023 May 16, 2023	BUY	$2.26 - $4.22 $15,141 - $28,274	6,700 Added 25.48%	33,000 $82,000
Q4 2022 Feb 14, 2023	BUY	$2.76 - $3.71 $35,880 - $48,230	13,000 Added 97.74%	26,300 $83,000
Q3 2022 Nov 14, 2022	SELL	$2.93 - $3.96 $809,266 - $1.09 Million	-276,200 Reduced 95.41%	13,300 $40,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $25.3M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.